Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00479791 · ClinicalTrials.gov registry record · NA

Lipid, Glycemic, and Insulin Responses to Meals Rich in Different Fatty Acids

A NA study of Type 2 Diabetes Mellitus, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT00479791: Completed NA study of Type 2 Diabetes Mellitus, sponsored by University of Texas Southwestern Medical Center.

NCT00479791 is a NA study of Type 2 Diabetes Mellitus that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 11 participants, below the 2,960-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00479791, a NA study of Type 2 Diabetes Mellitus, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

A meal rich in very-long chain omega-3 fatty acids or oleic acid may lower postprandial insulin levels in comparison to a meal rich in linoleic acid or palmitic acid. A meal rich in very long-chain omega-3 fatty acids may lower postprandial triglyceride levels compared to other fatty acids.

Conditions Studied

Interventions

  • BEHAVIORAL Test meals rich in different fatty acids

Study Locations (1)

Texas

  • UT Southwestern Medical Center at Dallas - Dallas

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 1997-04
Est. Completion 1999-06
Phase NA

What the finished NCT00479791 record still lists

NCT00479791 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 2,960-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Test meals rich in different fatty acids is the first listed.

NCT00479791 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00479791 about?

NCT00479791 is a clinical study titled "Lipid, Glycemic, and Insulin Responses to Meals Rich in Different Fatty Acids". A meal rich in very-long chain omega-3 fatty acids or oleic acid may lower postprandial insulin levels in comparison to a meal rich in linoleic acid or palmitic acid. A meal rich in very long-chain omega-3 fatty acids may lower postprandial triglyceride levels compared to other fatty acids.

What is the current status of trial NCT00479791?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 1997-04. Estimated completion is 1999-06.

What conditions does trial NCT00479791 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT00479791?

The interventions under investigation include: Test meals rich in different fatty acids (BEHAVIORAL).

Who is sponsoring clinical trial NCT00479791?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00479791 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00479791's enrollment target sits among peer trials

11 127th of 130 higher than 4 of 130 other Type 2 Diabetes Mellitus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00479791, the US trial registry maintained by the National Library of Medicine. NCT00479791 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.